06-Oct-2011 - Vetter says it will reduce API wastage through its new US production facility for the filling of syringes, cartridges and vials.
05-Oct-2011 - Solvias and RohnerChem have set up a research and manufacturing services partnership designed to accelerate the production, scale-up and commercialisation of APIs.
05-Oct-2011 - The FDA has awarded a $35m (€26m) grant to make US drug production less expensive and reverse the offshoring trend.
04-Oct-2011 - Bespak has won its second nasal delivery device development deal in as many months for a major global manufacturer of generic medicines.
03-Oct-2011 - CDMO Aesica is to add manufacturing capacity in Asia and the US following a cash injection from private equity firm Silverfleet Capital.
28-Sep-2011 - Lonza may build a stem cell production facility dedicated to manufacturing Mesoblast products after inking an alliance.
28-Sep-2011 - Contract generics packaging demand and possible acquisitions of up to €300m ($408m) will drive growth at United Drug, an analyst reports.
27-Sep-2011 - Cambridge Major Laboratories Europe (CMLE) is set to start commercial API manufacturing at its facility in the Netherlands after approval by Dutch regulators.
21-Sep-2011 - Rx-360 has begun its audit sharing programme to increase knowledge about suppliers and the quality of pharmaceutical raw materials.
19-Sep-2011 - Alkermes has celebrated the launch of its new Irish drug delivery and formulation business by winning a new multimillion dollar manufacturing contract with a ‘top 10 pharma.’
15-Sep-2011 - The FDA needs additional powers to update its “antiquated, domestically-focused statute” and end the “competitive advantage of non-compliance”, an agency official said.
14-Sep-2011 - The FDA has sent a warning letter to Lonza’s Hopkinton, MA plant after inspectors found faults with how it produces an oncology API for Eisai.
14-Sep-2011 - Biocon has begun work on the Malaysian biopharm plant that will serve its deal with Pfizer, and is now providing Lipitor ingredients.
13-Sep-2011 - Contract manufacturer CMC Biologics has ramped-up bioreactor capacity to meet demand for biologic drugs for Phase III clinical trials and beyond.
07-Sep-2011 - CellCura has inked an agreement with IDT Biologika for the testing and adaptation of its protein-free (PF) media for the production of cell lines for vaccine manufacturing.
07-Sep-2011 - AmerisourceBergen has bought informatics firm IntrinsiQ for $35m (€25m) continuing the spending spree it began earlier this week with the acquisition of market access consultancy Premier Source.
06-Sep-2011 - Chesapeake will buy leaflet and label maker Cortegra to strengthen its manufacturing position in the US pharmaceutical packaging market.
06-Sep-2011 - Japanese CMO Toyobo says it will increase capacity for injectable drugs to secure its position as a service provider in the expanding biopharmaceutical sector.
31-Aug-2011 - Vivalis cut its operating loss after demand for its vaccine production cell line drove triple-digit revenue growth.
31-Aug-2011 - Unilife sales tumbled in the fourth quarter due to closure of its contract manufacturing operations and a drop in milestone payments.
29-Aug-2011 - Batavia Bioservices has gained access to simulated moving bed (SMB) technology by collaborating with Xendo.
23-Aug-2011 - Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
16-Aug-2011 - Surging anti-viral sales drove fine chemical growth at Ampac in Q3, but the unit posted a loss after missing efficiency and throughput targets.
11-Aug-2011 - Close to two-thirds of biopharm companies plan to increase reliance on 3PL providers and global manufacturers in coming years, a survey found.
10-Aug-2011 - Akela Pharma is focusing on its CMO and expanding it through acquisitions after its partner exited their drug development programme.